Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 21

Trial Status

Completed1
Recruiting2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT07220993Phase 1Recruiting
Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells
T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaT-non-Hodgkin Lymphoma
PrincipalinvestigatorStart date: 2026-05-12
NCT03081910Phase 1Recruiting
Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen
T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaT-non-Hodgkin Lymphoma
PrincipalinvestigatorStart date: 2017-11-01
NCT00539695Phase 2Completed
Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaALL+7 more
Principalinvestigator

Research Network

Collaboration Network

4 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

LaQuisa Hill, MD

The Methodist Hospital Research Institute

Moderately Similar
3 trials

Shared therapeutic areas:

T-Cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaT-non-Hodgkin Lymphoma

Worked with same sponsors:

Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of Medicine+1 more
Collaborated on 1 trial
Similarity Score34%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteHodgkin Disease+4 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score16%

Yves Beguin, MD, PhD

CHU-ULg

Related
7 trials

Shared therapeutic areas:

Hodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myelogenous, Chronic, BCR-ABL Positive+4 more
Similarity Score16%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyelodysplastic Syndromes+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score12%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Non-HodgkinLeukemia, Myeloid, Acute+2 more
Similarity Score12%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

Related
18 trials

Shared therapeutic areas:

Myelodysplastic SyndromesLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma+2 more
Similarity Score12%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL Positive+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-Lymphoma+1 more
Similarity Score9%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteHodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-Lymphoma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteAmlMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score7%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT07220993Phase 1PrincipalInvestigator

Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells

T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaT-non-Hodgkin Lymphoma
Recruiting
NCT03081910Phase 1PrincipalInvestigator

Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen

T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaT-non-Hodgkin Lymphoma
Recruiting
NCT00539695Phase 2PrincipalInvestigator

Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD

Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaALL+7 more
Completed

All 3 trials loaded